User profiles for G. Hochhaus

Gunther Hochhaus

Professor, University of Florida
Verified email at cop.ufl.edu
Cited by 7678

Pharmacokinetic aspects of biotechnology products

L Tang, AM Persky, G Hochhaus, B Meibohm - Journal of pharmaceutical …, 2004 - Elsevier
… Kinetic analysis of the in vivo tissue distribution of the granulocyte colony stimulating factor
(G-… clearance might be due to the downregulation of G-CSF receptors on the cell surface.123 …

Pharmacokinetics and pharmacodynamics of inhaled corticosteroids

H Derendorf, G Hochhaus, B Meibohm… - Journal of Allergy and …, 1998 - Elsevier
There are significant differences in the pharmacokinetic properties of inhaled corticosteroids
currently used in medical practice. All are rapidly cleared from the body but they show …

Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthma

G Hochhaus, L Brookman, H Fox… - … medical research and …, 2003 - Taylor & Francis
Objective: Omalizumab (Xolair ), is a recombinant humanised monoclonal anti-immunoglobulin
E (IgE) antibody, for the treatment of allergic asthma. This review describes how the …

Pharmacokinetics of the dietary supplement creatine

AM Persky, GA Brazeau, G Hochhaus - Clinical pharmacokinetics, 2003 - Springer
… an unrealistic 682.5 µmol/min or >5 g/h (or >128 g/24 hours).[63] … g/day) has been shown
to increase urinary creatine levels, and after more than 3 days of loading at 4 × 5 g/day (20 g

[HTML][HTML] Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD

…, AR Clark, W Doub, A Hickey, G Hochhaus… - 2016 - Springer
The Biopharmaceutics Classification System (BCS), developed in the 1990s for oral
immediate release drugs, is utilized by R&D scientists and regulators to streamline product …

How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids

J Winkler, G Hochhaus, H Derendorf - Proceedings of the American …, 2004 - atsjournals.org
Bronchial asthma and allergic rhinitis are among the most common diseases of modern society
and to an increasing degree a major cause of illness, hospitalization, loss of productivity, …

Receptor‐based pharmacokinetic‐pharmacodynamic analysis of corticosteroids

H Derendorf, G Hochhaus, H Mölimann… - The Journal of …, 1993 - Wiley Online Library
The pharmacodynamics of three corticosteroids were investigated after intravenous
administration of the phosphate esters of methylprednisolone, dexamethasone, and triamcinolone …

Comparative pharmacology, bioavailability, pharmacokinetics, and pharmacodynamics of inhaled glucocorticosteroids

M Hübner, G Hochhaus… - … and Allergy Clinics, 2005 - immunology.theclinics.com
Glucocorticoids are important anti-inflammatory substances that play a major role in the
treatment of local and systemic inflammations. Knowledge about the pharmacokinetics and …

Soft drugs—10. Blanching activity and receptor binding affinity of a new type of glucocorticoid: loteprednol etabonate

P Druzgala, G Hochhaus, N Bodor - The Journal of Steroid Biochemistry …, 1991 - Elsevier
… Chloromethylchlorosulfate (4.75 g, 0.029 mol) in methylene … g. The product was crystallized
from hot acetone (100 ml). … and Hochhaus G.: Receptor binding affinities of commercial …

Pharmacokinetic/pharmacodynamic aspects of aerosol therapy using glucocorticoids as a model

G Hochhaus, H Möllmann, H Derendorf… - The Journal of …, 1997 - Wiley Online Library
Glucocorticoids are predominantly prescribed in asthma therapy as aerosols to achieve high
pulmonary effects with reduced systemic spill‐over and pronounced pulmonary selectivity. …